Genmab A/S (GMAB) Earnings Date, Estimates & Call Transcripts $21.04 +0.25 (+1.20%) As of 03:40 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Feb. 12) $0.28 Actual EPS (Feb. 12) $0.57 Beat By $0.29 Genmab A/S issued Q4 2024 earnings on February 12, 2025, reporting an EPS of $0.57, which topped analysts' consensus estimates of $0.28 by $0.29. With a trailing EPS of $1.74 and a P/E Ratio of 12.13, Genmab A/S's earnings are expected to grow 22.76% next year, from $1.45 to $1.78 per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report Slide DeckGMAB Upcoming EarningsGenmab A/S's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 12:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Genmab A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genmab A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGMAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMAB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Genmab A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$0.17$0.21$0.19Q2 20251$0.44$0.44$0.44Q3 20253$0.43$0.46$0.45Q4 20252$0.44$0.47$0.46FY 20258$1.48$1.58$1.53Q1 20262$0.29$0.37$0.33Q2 20262$0.53$0.57$0.55Q3 20262$0.51$0.62$0.57Q4 20262$0.52$0.67$0.60FY 20268$1.85$2.23$2.04 Genmab A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/12/2025Q4 2024$0.28$0.57+$0.29$0.85$884.02M-11/6/2024Q3 2024$0.32$0.29 -$0.03$0.29$838.20M$816.10M8/8/2024Q2 2024$0.29$0.22 -$0.07$0.13$734.60M$779.50M5/2/2024Q1 2024$0.16$0.16-$0.03$594.23M$603.30M2/14/2024Q4 2023$0.34$0.36+$0.02$0.58$678.14M$675.29M11/7/2023Q3 2023$0.34$0.47+$0.13$0.47$657.79M$692.80M8/3/2023Q2 2023$0.31$0.30 -$0.01$0.30$618.77M$613.43M5/10/2023Q1 2023$0.09$0.05 -$0.04$0.05$417.27M$411.37M Genmab A/S Earnings - Frequently Asked Questions When is Genmab A/S's earnings date? Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on GMAB's earnings history. What guidance has Genmab A/S issued on next quarter's earnings? Genmab A/S updated its FY 2025 earnings guidance on Wednesday, February, 12th. The company issued revenue guidance of $3.3 billion-$3.7 billion, compared to the consensus revenue estimate of $3.5 billion. Did Genmab A/S beat their earnings estimates last quarter? In the previous quarter, Genmab A/S (NASDAQ:GMAB) reported $0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $0.28 by $0.29. Learn more on analysts' earnings estimate vs. GMAB's actual earnings. How can I listen to Genmab A/S's earnings conference call? The conference call for Genmab A/S's latest earnings report can be listened to online. Listen to Conference Call How can I read Genmab A/S's conference call transcript? The conference call transcript for Genmab A/S's latest earnings report can be read online. Read Transcript How much revenue does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded annual revenue of $21.53 billion. How much profit does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded net income of $1.14 billion. GMAB has generated $1.74 earnings per share over the last four quarters. What is Genmab A/S's price-to-earnings ratio? Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 12.07 and a forward price-to-earnings ratio of 14.48. The price/earnings-to-growth ratio is 2.65. What is Genmab A/S's EPS forecast for next year? Genmab A/S's earnings are expected to grow from $1.45 per share to $1.78 per share in the next year, which is a 22.76% increase. More Earnings Resources from MarketBeat Related Companies TAK Earnings Date ARGX Earnings Date BNTX Earnings Date ONC Earnings Date SMMT Earnings Date TEVA Earnings Date ITCI Earnings Date RDY Earnings Date MRNA Earnings Date ASND Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:GMAB) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
